| Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. | |
| | |
MedLine Citation:
|
PMID: 12371635 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) both for attacks and for prevention of secondary amyloidosis. The overall non-responder rate varies from 5-10 to 40%. Thalidomide is known to blunt the acute phase response. We report the efficacy of the addition of thalidomide to colchicine in controlling the febrile attacks and acute phase response in a patient with FMF resistant to 2 mg colchicine per day. |
| | |
Authors:
|
E Seyahi; H Ozdogan; S Masatlioglu; H Yazici |
Related Documents
:
|
19235105 - Evaluation of the function of the vestibular system in patients with migraine. 16538425 - High prolactin levels as a worsening factor for migraine. 2522805 - Outpatient myelography: an acceptable and cost-effective technique. 21872095 - Chronic pancreatitis and exocrine insufficiency. 19235105 - Evaluation of the function of the vestibular system in patients with migraine. 7469835 - Eeg in phenylketonuria. attempt to establish clinical importance of eeg changes. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Clinical and experimental rheumatology Volume: 20 ISSN: 0392-856X ISO Abbreviation: Clin. Exp. Rheumatol. Publication Date: 2002 Jul-Aug |
Date Detail:
|
Created Date: 2002-10-09 Completed Date: 2003-06-13 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8308521 Medline TA: Clin Exp Rheumatol Country: Italy |
Other Details:
|
Languages: eng Pagination: S43-4 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Colchicine
/
therapeutic use* Drug Therapy, Combination Familial Mediterranean Fever / drug therapy* Humans Immunosuppressive Agents / therapeutic use* Male Middle Aged Thalidomide / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Immunosuppressive Agents; 50-35-1/Thalidomide; 64-86-8/Colchicine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adamantiades-Behçet's disease with inner ear involvement.
Next Document: Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis.